Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine

Because of the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), safe and effective vaccines are urgently required. The shortage of effective vaccines is a major challenge in many developing countries. We studied intradermal (ID) fractional dose BNT162b2 mRNA (Comirnaty®, Pfi...

Descripción completa

Detalles Bibliográficos
Autores principales: Temtanakitpaisan, Yutthapong, Saengnipanthkul, Suchaorn, Sarakosol, Nataporn, Maskasame, Sasinapa, Mongkon, Siwawoot, Buranrat, Benjaporn, Thammawat, Sutthiwan, Patamatamkul, Samadhi, Nernsai, Pattaranit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671541/
https://www.ncbi.nlm.nih.gov/pubmed/36415450
http://dx.doi.org/10.1016/j.jvacx.2022.100242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671541/
https://www.ncbi.nlm.nih.gov/pubmed/36415450
http://dx.doi.org/10.1016/j.jvacx.2022.100242

Ejemplares similares